Clinical Study
Aminoterminal Pro B-Type Natriuretic Peptide (NT-proBNP) Levels for Monitoring Interventions in Paediatric Cardiac Patients with Stenotic Lesions
Table 2
Patient characteristics, clinical and echocardiographic data in median with range.
| | Variable (unit) | All patients (n = 42) | Left stenosis (n = 25) | Right stenosis (n = 17) | Symptomatic* (n = 27) | Asymptomatic (n = 15) |
| | Median age: years (range) | 4.8 (0–17) | 3 (0–16) | 6.5 (0–17) | 4.4 (0–16) | 11.3 (0–17) |
| | Surgical versus catheterization interventions: | 9/33 | 7/18 | 2/15 | 8/19 | 1 /14 |
| | Median peak gradient before intervention (mm Hg per catheterization and/or ECHO in pts scheduled for operation) | 64 (10–120) | 50 (20–125) | 85 (10–120) | 64 (20–120) | 64 (10–125) |
| | Median peak gradient after intervention (mm Hg per catheterization and/or ECHO in patients scheduled for operation) | 10 (0–90) | 0 (0–40) | 36 (0–90) | 10 (0–80) | 20 (0–90) |
| | Median NT-proBNP before (pg/mL) | 280 (10–263000) | 263 (10–263000) | 312 (48–978) | 1570 (120–263.000) | 125 (10–944) |
| | Median NT-proBNP after (pg/mL) | 134 (10–34300) | 117 (20–34300) | 193 (69–490) | 480 (20–34300) | 115 (20–490) |
|
|
: increased modified Ross Score in pts 0–14 y or NYHA in pts > 14 y or arterial hypertension and diminished pulses in patients with coarctation.
|
